Objective: Shunting of the lateral ventricle and the posterior fossa cyst is the advocated surgical therapy for children with Dandy-Walker malformation (DWM) and associated aqueductal obstruction. The high rate of complications of combined shunting stimulated the authors to search for an alternative surgical solution. Clinical Presentation/Intervention: After transtentorial endoscopic ventriculocystostomy, a cystoventricular catheter, connected to a peritoneal shunt, was placed in a neonate with DWM and associated aqueductal obstruction. Immediately prior to ventriculocystostomy, the presence of a blocked third ventricular outflow was reconfirmed by contrast medium injection. Neuronavigation was required to define the surgical path from the lateral ventricle through the tentorium and the overlying small rim of brain parenchyma into the posterior fossa cyst. The postoperative clinical course was uneventful with radiologically proven reduction of the size of the ventricular system and the cyst. Conclusion: Cystoventriculoperitoneal shunt placement after transtentorial endoscopic ventriculostomy is a surgical alternative in very young children with DWM and associated aqueductal obstruction.

Keywords:
Dandy-Walker malformation, Hydrocephalus, Ventriculocystostomy
1.
Osborn AG: Posterior fossa malformations and cysts; in: Diagnostic Neuroradiology. Mosby, St Louis, 1995, pp 59–71.
2.
Benda CE: The Dandy-Walker syndrome or the so-called atresia of the foramen Magendie. J Neuropathol Exp Neurol 1954;13:14–29.
3.
Carmel PW, Antunes JL, Hilal SK, Gold AP: Dandy-Walker syndrome: Clinico-pathological features and re-evaluation of modes of treatment. Surg Neurol 1977;8:132–138.
4.
Raimondi AJ, Samuelson G, Yarzagaray L, Norton T: Atresia of the foramina of Luschka and Magendie: The Dandy-Walker cyst. J Neurosurg 1969;31:202–216.
5.
Bindal AK, Storrs BB, McLone DG: Occipital meningoceles in patients with the Dandy-Walker syndrome. Neurosurgery 1991;28:844–847.
6.
Gerszten PC, Albright AL: Relationship between cerebellar appearance and function in children with Dandy-Walker syndrome. Pediatr Neurosurg 1995;23:86–92.
7.
Mohanty A: Endoscopic third ventriculostomy with cystoventricular stent placement in the management of Dandy-Walker malformation: Technical case report of three patients. Neurosurgery 2003;53:1223–1228.
8.
Schroeder HW, Gaab MR: Endoscopic aqueductoplasty: Technique and results. Neurosurgery 1999;45:508–515.
9.
Buxton N, Macarthur D, Malucci C, Punt J, Vloeberghs M: Neuroendoscopic third ventriculostomy in patients less than 1 year old. Pediatr Neurosurg 1998;29:73–76.
10.
Hopf NJ, Grunert P, Fries G, Resch KDM, Perneczky A: Endoscopic third ventriculostomy: Outcome analysis of 100 consecutive procedures. Neurosurgery 1999;44:795–804.
11.
Ernestus RI, Kruger K, Ernst S, Lackner K, Klug N: Relevance of magnetic resonance imaging for ventricular endoscopy. Minim Invasive Neurosurg 2002;45:72–77.
12.
Rohde V, Reinges MH, Krombach GA, Gilsbach JM: The combined use of image-guided frameless stereotaxy and neuroendoscopy for the surgical management of occlusive hydrocephalus and intracranial cysts. Br J Neurosurg 1998;12:531–538.
13.
Rohde V, Mayfrank L, Ramakers VT, Gilsbach JM: Four-year experience with the routine use of the programmable Hakim valve in the management of children with hydrocephalus. Acta Neurochir (Wien) 1998;140:1127–1134.
14.
Domingo Z, Peter J: Midline developmental abnormalities of the posterior fossa: Correlation of classification with outcome. Pediatr Neurosurg 1996;24:111–118.
15.
Kalidasan V, Carroll T, Allcutt D, Fitzgerald RJ: The Dandy-Walker syndrome – A 10-year experience of its management and outcome. Eur J Pediatr Surg 1995;5(Suppl 1):16–18.
16.
Osenbach RK, Menezes AH: Diagnosis and management of the Dandy-Walker malformation: 30 years of experience. Pediatr Neurosurg 1992;18:179–189.
17.
Asai A, Hoffman HJ, Hendrick EB, Humphreys RP: Dandy-Walker syndrome: Experience at the Hospital for Sick Children, Toronto. Pediatr Neurosci 1989;15:66–73.
18.
Abtin K, Walker ML: Congenital arachnoid cyst and the Dandy-Walker complex; in Albright AL, Pollack IF, Adelson PD (eds): Principles and Practice of Pediatric Neurosurgery. New York, Thieme, 1999, pp 125–141.
19.
Hirsch JF, Pierre-Kahn A, Renier D, Sainte-Rose C, Hoppe-Hirsch E: The Dandy-Walker malformation. A review of 40 cases. J Neurosurg 1984;61:515–522.
20.
Gibson JB: Congenital hydrocephalus due to atresia of the foramen of Magendie. J Neuropathol Exp Neurol 1955;14:244–262.
21.
Kaiser G, Schut L, James HE, Bruce DA: Problems in diagnosis and treatment in the Dandy-Walker syndrome. Mod Probl Paediatr 1977;18:123–124.
22.
Kumar R, Jain MK, Chhabra DK: Dandy-Walker syndrome: Different modalities of treatment and outcome in 42 cases. Childs Nerv Syst 2001;17:348–352.
23.
Jones RF, Stening WA, Brydon M: Endoscopic third ventriculostomy. Neurosurgery 1990;26:86–91.
24.
Buxton N, Macarthur D, Mallucci C, Punt J, Vloeberghs M: Neuroendoscopy in the premature population. Childs Nerv Syst 1998;14:649–652.
25.
Griffith HB, Jamjoom AB: The treatment of childhood hydrocephalus by choroid plexus coagulation and artificial cerebrospinal fluid perfusion. Br J Neurosurg 1990;4:95–100.
26.
Cinalli G, Sainte-Rose C, Chumas P, Zerah M, Brunelle F, Lot G, Pierre-Kahn A, Renier D: Failure of third ventriculostomy in the treatment of aqueductal stenosis in children. J Neurosurg 1999;90:448–454.
27.
Beems T, Grotenhuis JA: Is the success rate of endoscopic third ventriculostomy age-dependent? An analysis of the results of endoscopic third ventriculostomy in young children. Childs Nerv Syst 2002;18:605–608.
28.
Rohde V, Gilsbach JM: Anomalies and variants of the endoscopic anatomy for third ventriculostomy. Minim Invasive Neurosurg 2000;43:111–117.
29.
Veto F, Horvath Z, Doczi T: Biportal endoscopic management of third ventricle tumors in patients with occlusive hydrocephalus: technical note. Neurosurgery 1997;40:871–875.
30.
Cedzich C, Lunkenheimer A, Baier G, Muller J, Kuhner A: Ultrasound-guided puncture of a Dandy-Walker cyst via the lateral and III ventricles. Childs Nerv Syst 1999;15:472–476.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.